Qualitative and quantitative insights were obtained by interviewing supply-side and demand-side stakeholders during the primary research process. The supply-side sources consisted of CEOs, VPs of Manufacturing, regulatory affairs chiefs, R&D directors, and commercial directors from potassium iodide manufacturers, specialty chemical companies, and iodine mining operations. Procurement leads from pharmaceutical companies, food processing industry buyers, agricultural feed formulators, water treatment specialists, nuclear facility safety officers, and quality control managers from salt iodization programs constituted demand-side sources. The primary research validated market segmentation across purity levels (99.0-99.5%, 99.5-99.9%, >99.9%), confirmed production process efficiencies (electrolysis, crystallization, ion exchange, chemical synthesis), and gathered insights on pricing volatility, supply chain constraints, and regulatory compliance requirements.
Primary Respondent Breakdown:
By Designation: C-level Primaries (32%), Director Level (30%), Others (38%)
By Region: North America (32%), Europe (30%), Asia-Pacific (28%), Rest of World (10%)
Global market valuation was derived through revenue mapping and production volume analysis. The methodology included:
Identification of 40+ key manufacturers across North America, Europe, Asia-Pacific, and Latin America
Product mapping across crystalline, granular, powdered potassium iodide, and saturated solutions by purity grade
Analysis of reported and modeled annual revenues specific to potassium iodide portfolios
Coverage of manufacturers representing 70-75% of global market share in 2024
Extrapolation using bottom-up (application volume × ASP by region) and top-down (manufacturer revenue validation) approaches to derive segment-specific valuations for pharmaceutical, industrial, agriculture, and food additive applications